Incyte/MorphoSys Await EU Verdict On Tafasitamab For DLBCL

Updated Results From Monoclonal Antibody’s Phase II Trial Released In June

 
• By Vibha Sharma
  
Lymphoma (blood cancer type) - serious illness word cloud concept.
DLBCL is the most common type of non-Hodgkin lymphoma in adults • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography